-
Markets Flatten Out After Early Trade Rally on Thursday
Market Update: Benchmark equity indices initially surged in early trade on Thursday, Reliance Industries saw notable gains. Check it out
-
Indian Stock Market.
Indian benchmark indices closed lower by more than 1%.
-
Will Pharma Sector Get its Mojo Back?
Despite this challenging macro environment, we remain optimistic about the growth outlook of the Indian pharmaceutical companies
-
Nifty, NSE scale new heights
As per NSEs financials for Q1 FY24, the exchange earned a total revenue of Rs 3,357 crore, registering a 22% y-o-y increase.
-
Tata Steel, PFC, Wipro, Sun Pharma in focus
Tata Steel reported a 661.34% surge in consolidated net profit to Rs 11918.11 crore on 56.45% rise in total income to Rs 61459.04 crore in Q2 FY22.
-
Stay away from IT, metals in the near term: Gautam Shah, Goldilocks
"While India continues to be one of the better performers in global markets, the short term charts look overbought"
-
Despite stretched valuations, there is still upside in cyclicals
As capital markets go beyond liquidity support from central banks, investor focus is shifting towards growth revisions.
-
CLSA is bullish on these two pharma stocks
Most pharma companies provided a broad roadmap on the transition to complex generic products while maintaining a calibrated R&D allocation strategy
-
Trading ideas: Stock recommendations for August 20, Friday
Chandan Taparia of Motilal Oswal Financial Services is positive on Bata India with a target price of Rs 1,820.
-
Sun Pharma posts strong Q1FY22; should you buy?
Post stellar Q1 result most brokerages have re-rated stock and believe that it can touch Rs 900 apiece in the near term
